Although advancements in genomic and epigenetic research have deepened our understanding of acute myeloid leukemia (AML). only one-third of patients can achieve durable remission. Growing evidence suggests that the immune microenvironment in bone marrow influences prognosis and survival in AML. There is a specific association between CD8+ T cells and the prognosis of AML patients. https://www.popularfilm.blog/